Non-interventional study
Effectiveness of Pfizer-BioNTech COVID-19 mRNA vaccine against severe illness in the elderly in Finland (RWE_COVID19_2023)
Finland
EU PAS number:
EUPAS1000000376
First published:
29/04/2025
StudyOngoing
Observational Cohort Study of Lasmiditan Exposure and Motor Vehicle Accidents in the United States (MI DRIVE) H8H-MC-B006
United States
EU PAS number:
EUPAS1000000347
First published:
20/11/2024
StudyPlanned
A Drug Utilization Study to Evaluate the Effectiveness of Risk Minimization Measures (RMMs) for Abrocitinib in the EU Using Electronic Healthcare Data (B7451085)
Denmark
France
Hungary
Spain
Sweden
EU PAS number:
EUPAS1000000345
First published:
07/01/2025
StudyOngoing
A Retrospective Data Collection and Analysis Study of Patients With Sickle Cell Disease (SCD) Who Have Been Treated With Oxbryta® (Voxelotor)
United States
EU PAS number:
EUPAS1000000334
First published:
14/10/2024
StudyOngoing
Etoricoxib in real-world clinical setting: it’s treatment outcome in patients with rheumatic diseases (RED)
Hungary
Latvia
EU PAS number:
EUPAS1000000317
First published:
23/09/2024
StudyFinalised
Postauthorisation Safety Study (PASS) of Avatrombopag in Patients With Severe Chronic Liver Disease (CLD)
Austria
Denmark
Netherlands
Spain
EU PAS number:
EUPAS1000000310
First published:
14/04/2025
StudyPlanned
A retrospective-prospective observational study to assess Landiolol utilization patterns in patients with supraventricular tachycardia, for rapid control of ventricular rate in patients with atrial fibrillation or atrial flutter, for short-term control of the ventricular rate, or for non-compensatory sinus tachycardia (LANDI-UP)
Austria
Czechia
Germany
Greece
Hungary
Netherlands
Poland
Slovenia
EU PAS number:
EUPAS1000000297
First published:
03/12/2024
StudyFinalised
Nested case-control study evaluating effectiveness of immunization of girls and women of childbearing potential with GARDASIL(TM)/GARDASIL(TM) 9 against juvenile-onset recurrent respiratory papillomatosis (JoRRP) in Sweden, Denmark, and Norway (V503-095)
Denmark
Norway
Sweden
EU PAS number:
EUPAS1000000286
First published:
17/12/2024
StudyOngoing
Evaluation of the effectiveness of additional risk minimisation measures (aRMMs) that aim to reduce the risks of phototoxicity, squamous cell carcinoma (SCC) of the skin and hepatic toxicity in patients receiving voriconazole in Saudi Arabia
Saudi Arabia
EU PAS number:
EUPAS1000000266
First published:
28/11/2024
StudyOngoing
A long-term non-interventional study to assess the incidence of skin malignancies in patients with dystrophic and junctional epidermolysis bullosa receiving treatment with Filsuvez (FOSTER)
Austria
France
Germany
Greece
Italy
Netherlands
Spain
United Kingdom
EU PAS number:
EUPAS1000000244
First published:
05/07/2024
StudyPlanned